Source: BioSpace

InterAx: InterAx Biotech Announces Being the Recipient of a Highly Competitive European Grant to Fund Drug Development and Reports Financing Highlights

InterAx Biotech AG announces being awarded a highly competitive and prestigious grant to apply its drug discovery and development platform to the breakthrough technology programs sponsored by the EU commission.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Christopher Prior's photo - CEO of InterAx

CEO

Christopher Prior

CEO Approval Rating

83/100

Read more